Analysis of correlative factors of female coronary slow-flow phenomenon: A retrospective study

Xin Chen1, Alian Zhang, Zuojun Xu

  • 1Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Medicine
|May 24, 2024
PubMed

Insights

This study identifies unique risk factors for coronary slow-flow phenomenon (CSFP) in women, including smoking, elevated free fatty acids (FFA), and lower free thyroxine (FT4) levels. These findings highlight important differences in CSFP development among female patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Endocrinology

Background:

  • Coronary slow-flow phenomenon (CSFP) is characterized by delayed coronary blood flow without significant stenosis.
  • CSFP predominantly affects male patients, prompting investigation into distinct risk factors in females.
  • Understanding female-specific CSFP risk factors is crucial for targeted prevention and treatment strategies.

Purpose of the Study:

  • To identify distinct clinical and biochemical risk factors associated with CSFP in female patients.
  • To compare these factors between female CSFP patients and a control group with normal coronary arteries.
  • To determine independent predictors of CSFP in this population.

Main Methods:

  • A single-center retrospective study involving 92 female CSFP patients and 92 controls.
  • Coronary angiography was used for CSFP diagnosis.
  • Comparative analysis of clinical data, lipid profiles, and thyroid hormone levels.

Main Results:

  • CSFP patients showed higher rates of smoking, diabetes mellitus, and elevated total cholesterol and free fatty acids (FFA).
  • Lower levels of apolipoprotein E (ApoE), free thyroxine (FT4), and total thyroxine (TT4) were observed in the CSFP group.
  • Smoking, FFA, ApoE, and FT4 were identified as independent risk factors for CSFP.

Conclusions:

  • Female CSFP patients present with distinct risk factor profiles compared to the general population.
  • Smoking, elevated FFA, and altered thyroid hormone levels (specifically lower FT4) are significant independent risk factors for CSFP in women.
  • These findings underscore the need for tailored risk assessment and management of CSFP in female patients.

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...